Skip to content
TriangleGet started
← Back to this collection

PUBLICATIONS · 34606378

Ibrutinib Plus Rituximab Versus Placebo Plus Rituximab for Waldenström's Macroglobulinemia: Final Analysis From the Randomized Phase III iNNOVATE Study.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
J Clin Oncol
Publication date
2022 Jan 1
First author
Buske C

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Future Oncol. 2023 Feb;19(5):345-353. doi: 10.2217/fon-2022-1015.
    note
    Source null
    related pmid
    36815271
    relationship
    Comment in

Authors and identifiers

  1. name
    Buske C
    type
    Author
  2. name
    Tedeschi A
    type
    Author
  3. name
    Trotman J
    type
    Author
  4. name
    García-Sanz R
    type
    Author
  5. name
    MacDonald D
    type
    Author
  6. name
    Leblond V
    type
    Author
  7. name
    Mahe B
    type
    Author
  8. name
    Herbaux C
    type
    Author
  9. name
    Matous JV
    type
    Author
  10. name
    Tam CS
    type
    Author
  11. name
    Heffner LT
    type
    Author
  12. name
    Varettoni M
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Buske C
    type
    Author
  2. name
    Tedeschi A
    type
    Author
  3. name
    Trotman J
    type
    Author
  4. name
    García-Sanz R
    type
    Author
  5. name
    MacDonald D
    type
    Author
  6. name
    Leblond V
    type
    Author
  7. name
    Mahe B
    type
    Author
  8. name
    Herbaux C
    type
    Author
  9. name
    Matous JV
    type
    Author
  10. name
    Tam CS
    type
    Author
  11. name
    Heffner LT
    type
    Author
  12. name
    Varettoni M
    type
    Author
bibliography ids
  1. nci-bib-b4b094ea04a66de8725694df
book metadata
content sha256
7cf480b9240a041eeedc911949c229082bb62da5668cf7fb1f040bebdeff468c
document type
citation
dois
  1. 10.1200/JCO.21.00838
electronic publication date
display
2021 Oct 4
precision
day
year
2021
evidence scope
bibliographic_metadata_only
id
pubmed:34606378
immutable id
pubmed:34606378@7cf480b9240a041eeedc911949c229082bb62da5668cf7fb1f040bebdeff468c
journal
abbreviation
J Clin Oncol
issn electronic
1527-7755
issn print
0732-183X
issue
1
name
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
nlm unique id
8309333
pages
52-62
volume
40
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Future Oncol. 2023 Feb;19(5):345-353. doi: 10.2217/fon-2022-1015.
    note
    Source null
    related pmid
    36815271
    relationship
    Comment in
outcomes validated
false
pmid
34606378
provenance
batch id
192b6392c165c6b06274
provider
NCBI PubMed ESummary
record sha256
95bc6c69bc56fd23d75133f2959b4d33dcb267218126bcb9192429bff1d1b42e
response sha256
7d81e9fb11ee99e6ad4116aecd61ba71cd6bf76f2a8f8f6d15c5c85e9c6c56b4
retrieved at
2026-09-09T23:48:02.713075+00:00
publication date
display
2022 Jan 1
precision
day
year
2022
publication types
  1. Clinical Trial, Phase III
  2. Comparative Study
  3. Journal Article
  4. Multicenter Study
  5. Randomized Controlled Trial
  6. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/34606378/
title
Ibrutinib Plus Rituximab Versus Placebo Plus Rituximab for Waldenström's Macroglobulinemia: Final Analysis From the Randomized Phase III iNNOVATE Study.

Preserved source evidence · Independent clinical review pending · Not medical advice